Pediatrix Medical Group, Inc. Stock Price, News & Analysis

Mednax, Inc. (NYSE: MD) will hold an investor conference call and webcast on February 17, 2022, at 9:00 a.m. ET, to discuss operational results for the year ended December 31, 2021. A detailed press release will precede the call on the same date. Mednax, a national medical group, specializes in physician services primarily in pediatrics, obstetrics, and neonatology, operating across 38 states and Puerto Rico with over 4,700 clinicians. For more information, visit mednax.com/investors.

Mednax, Inc. (NYSE: MD) has acquired Night Lite Pediatrics, LLC, a pediatric urgent care practice with 13 clinics in Florida. Founded in 2005, Night Lite employs 30 physicians and offers urgent care, telemedicine, and COVID-19 services. This cash transaction is expected to be immediately accretive to earnings, enhancing Mednax's strategy to develop innovative pediatric services powered by Brave Care technology. The clinics will be rebranded to Pediatrix, further expanding Mednax's presence in pediatric care in Florida.

Mednax, Inc. (NYSE: MD) has priced a private offering of $400 million of 5.375% Senior Notes due in 2030. The offering is set to close on February 11, 2022, subject to customary conditions. Net proceeds will be used to redeem existing 6.25% Senior Notes due in 2027. The Notes will be sold exclusively to qualified institutional buyers and non-U.S. persons, in accordance with Rule 144A and Regulation S of the Securities Act.

Mednax, Inc. (NYSE: MD) is proposing a private offering of $400 million in Senior Notes due 2030. The offering is exempt from registration under the Securities Act of 1933 and will be directed to qualified institutional buyers. The proceeds will be used to redeem outstanding 6.25% Senior Notes due 2027. The company aims to improve its financial position and reduce interest expenses. This move reflects Mednax's ongoing strategy to optimize its capital structure amidst changing market conditions.

Mednax, Inc. (NYSE: MD) will present at Bank of America’s 2021 Leveraged Finance Conference on November 30, 2021, at 2:15 p.m. EST. The presentation will be available via live audio webcasts. Mednax, founded in 1979, is a national medical group that provides physician services through its Pediatrix and Obstetrix medical groups. The company operates with over 2,300 physicians in 39 states and Puerto Rico, focusing on evidence-based care and enhancing patient outcomes.

Mednax, Inc. (NYSE: MD) will present at Credit Suisse’s 30th Annual Healthcare Conference on November 10, 2021, at 1:50 p.m. EST, via live audio webcasts. The company is a national medical group with over 2,300 physicians across 39 states and Puerto Rico, focusing on high-quality, cost-effective healthcare services in pediatrics and obstetrics. Established in 1979, Mednax utilizes evidence-based tools and telehealth programs to improve patient outcomes.

Mednax, Inc. (NYSE: MD) reported Q3 2021 earnings of $0.37 per share and adjusted EPS of $0.46, with net revenue reaching $493 million, up from $461 million YoY. Income from continuing operations was $32 million, and adjusted EBITDA was $73 million. Key growth areas included a 5.9% increase in same-unit revenue, primarily driven by a 6.5% rise in patient volume. Mednax's investment in Brave Care aims to enhance pediatric services. Cash reserves stood at $358 million, reflecting a decline from $1.12 billion at the start of the year due to debt redemption efforts.

Mednax, Inc. (NYSE: MD) will hold an investor conference call on October 28, 2021, at 9:00 a.m. ET, to discuss quarterly operational results for the quarter and nine months ended September 30, 2021. A detailed press release will be available on the same morning before market open. The call will be accessible via Mednax’s website. Mednax focuses on delivering high-quality medical services through over 2,300 physicians across 39 states and Puerto Rico.

Mednax, Inc. (NYSE: MD) endorses the CDC's COVID-19 vaccination recommendations, emphasizing the importance of safeguarding at-risk populations, particularly pregnant women and children. With over 400 million doses administered in the U.S., the firm highlights that unvaccinated individuals account for approximately 90% of COVID-19 deaths. This position aligns with other prominent medical associations dedicated to maternal and pediatric care. Mednax's commitment to improving patient outcomes is reinforced through its extensive network of over 2,300 healthcare professionals across 39 states and Puerto Rico.